| pubmed-article:8955657 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:8955657 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:8955657 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:8955657 | lifeskim:mentions | umls-concept:C0279637 | lld:lifeskim |
| pubmed-article:8955657 | lifeskim:mentions | umls-concept:C0008838 | lld:lifeskim |
| pubmed-article:8955657 | lifeskim:mentions | umls-concept:C0016360 | lld:lifeskim |
| pubmed-article:8955657 | lifeskim:mentions | umls-concept:C1274040 | lld:lifeskim |
| pubmed-article:8955657 | lifeskim:mentions | umls-concept:C1559154 | lld:lifeskim |
| pubmed-article:8955657 | lifeskim:mentions | umls-concept:C0205225 | lld:lifeskim |
| pubmed-article:8955657 | lifeskim:mentions | umls-concept:C1707491 | lld:lifeskim |
| pubmed-article:8955657 | pubmed:issue | 12 | lld:pubmed |
| pubmed-article:8955657 | pubmed:dateCreated | 1997-1-3 | lld:pubmed |
| pubmed-article:8955657 | pubmed:abstractText | This prospective phase II study was designed to test the activity and toxicity of a regimen of fluorouracil (5-FU) and cisplatin (CDDP) in combination with radiation therapy in the treatment of epidermoid cancer of the anal canal. | lld:pubmed |
| pubmed-article:8955657 | pubmed:language | eng | lld:pubmed |
| pubmed-article:8955657 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8955657 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:8955657 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8955657 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8955657 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:8955657 | pubmed:month | Dec | lld:pubmed |
| pubmed-article:8955657 | pubmed:issn | 0732-183X | lld:pubmed |
| pubmed-article:8955657 | pubmed:author | pubmed-author:KendaRR | lld:pubmed |
| pubmed-article:8955657 | pubmed:author | pubmed-author:ZucaliRR | lld:pubmed |
| pubmed-article:8955657 | pubmed:author | pubmed-author:DockPP | lld:pubmed |
| pubmed-article:8955657 | pubmed:author | pubmed-author:La MonicaGG | lld:pubmed |
| pubmed-article:8955657 | pubmed:author | pubmed-author:MeroniEE | lld:pubmed |
| pubmed-article:8955657 | pubmed:author | pubmed-author:LozzaLL | lld:pubmed |
| pubmed-article:8955657 | pubmed:author | pubmed-author:EboliMM | lld:pubmed |
| pubmed-article:8955657 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:8955657 | pubmed:volume | 14 | lld:pubmed |
| pubmed-article:8955657 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:8955657 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:8955657 | pubmed:pagination | 3121-5 | lld:pubmed |
| pubmed-article:8955657 | pubmed:dateRevised | 2006-4-24 | lld:pubmed |
| pubmed-article:8955657 | pubmed:meshHeading | pubmed-meshheading:8955657-... | lld:pubmed |
| pubmed-article:8955657 | pubmed:meshHeading | pubmed-meshheading:8955657-... | lld:pubmed |
| pubmed-article:8955657 | pubmed:meshHeading | pubmed-meshheading:8955657-... | lld:pubmed |
| pubmed-article:8955657 | pubmed:meshHeading | pubmed-meshheading:8955657-... | lld:pubmed |
| pubmed-article:8955657 | pubmed:meshHeading | pubmed-meshheading:8955657-... | lld:pubmed |
| pubmed-article:8955657 | pubmed:meshHeading | pubmed-meshheading:8955657-... | lld:pubmed |
| pubmed-article:8955657 | pubmed:meshHeading | pubmed-meshheading:8955657-... | lld:pubmed |
| pubmed-article:8955657 | pubmed:meshHeading | pubmed-meshheading:8955657-... | lld:pubmed |
| pubmed-article:8955657 | pubmed:meshHeading | pubmed-meshheading:8955657-... | lld:pubmed |
| pubmed-article:8955657 | pubmed:meshHeading | pubmed-meshheading:8955657-... | lld:pubmed |
| pubmed-article:8955657 | pubmed:meshHeading | pubmed-meshheading:8955657-... | lld:pubmed |
| pubmed-article:8955657 | pubmed:meshHeading | pubmed-meshheading:8955657-... | lld:pubmed |
| pubmed-article:8955657 | pubmed:meshHeading | pubmed-meshheading:8955657-... | lld:pubmed |
| pubmed-article:8955657 | pubmed:meshHeading | pubmed-meshheading:8955657-... | lld:pubmed |
| pubmed-article:8955657 | pubmed:meshHeading | pubmed-meshheading:8955657-... | lld:pubmed |
| pubmed-article:8955657 | pubmed:meshHeading | pubmed-meshheading:8955657-... | lld:pubmed |
| pubmed-article:8955657 | pubmed:year | 1996 | lld:pubmed |
| pubmed-article:8955657 | pubmed:articleTitle | Primary chemoradiation therapy with fluorouracil and cisplatin for cancer of the anus: results in 35 consecutive patients. | lld:pubmed |
| pubmed-article:8955657 | pubmed:affiliation | Division of Surgery of the Digestive Tract, Istituto Nazionale Tumori, Milan, Italy. | lld:pubmed |
| pubmed-article:8955657 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:8955657 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:8955657 | pubmed:publicationType | Clinical Trial, Phase II | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8955657 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8955657 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8955657 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8955657 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8955657 | lld:pubmed |
